Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Orthofix Medical Inc.OFIX · Entity 1975 | CFO | February 28, 2023 | March 02, 2023 |
| Sonendo, Inc.SONX · Entity 9738 | Chief Financial Officer | September 17, 2024 | September 19, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Orthofix Medical Inc.
Report date February 28, 2023 · Filed March 02, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 99,670 |
Reported balance
After 2023-02-28 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-02-28 · Tax withholding · Disposed 3,783 · Balance 99,670 F1: Includes 52,384 unvested restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 52,384 unvested restricted stock units.
Sonendo, Inc.
Report date September 17, 2024 · Filed September 19, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,320,000 |
Reported balance
After 2024-09-17 transaction · row 1
1 source rowRow 1 · 2024-09-17 · Grant · Acquired 600,000 · Balance 1,320,000 F1: Represents an award of Restricted Stock Units ("RSUs") granted to the Reporting Person on September 17, 2024 (the "Grant Date"). Each RSU represents a contingent right to receive one share of common stock, par value $0.001 per share of Sonendo, Inc. (the "Issuer"). The RSUs will vest 25% on the first anniversary of the grant date and 6.25% at the end of each three-month period thereafter, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting dates. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of Restricted Stock Units ("RSUs") granted to the Reporting Person on September 17, 2024 (the "Grant Date"). Each RSU represents a contingent right to receive one share of common stock, par value $0.001 per share of Sonendo, Inc. (the "Issuer"). The RSUs will vest 25% on the first anniversary of the grant date and 6.25% at the end of each three-month period thereafter, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting dates.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SeaSpine Holdings Corp
Report date January 05, 2023 · Filed January 09, 2023
Section 16 reporting ended · disclosed 2023-01-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 1
1 source rowRow 1 · 2023-01-05 · Disposition to issuer · Disposed 102,563 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 42,696 Orthofix Medical Inc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-01-05 · Disposition to issuer · Disposed 13,840 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. F4: These restricted stock units were assumed by Orthofix in the merger and replaced by 5,761 Orthofix restricted stock units. F3: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-01-05 · Disposition to issuer · Disposed 51,795 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. F6: These restricted stock units were assumed by Orthofix in the merger and replaced by 21,562 Orthofix restricted stock units. F5: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.68 · Expires 2023-08-01 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-01-05 · Disposition to issuer · Disposed 62,000 · Balance 0 F8: This option was assumed by Orthofix in the merger and replaced with an option to purchase 25,810 shares of Orthofix at a price of $37.67 per share. F7: The option vests as to 25% of the underlying shares on May 1, 2016 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.19 · Expires 2024-01-27 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-01-05 · Disposition to issuer · Disposed 64,599 · Balance 0 F10: This option was assumed by Orthofix in the merger and replaced with an option to purchase 26,892 shares of Orthofix at a price of $34.09 per share. F9: The option vests in sixteen substantially equal quarterly installments beginning on March 31, 2016. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.24 · Expires 2027-01-01 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2023-01-05 · Disposition to issuer · Disposed 17,818 · Balance 0 F12: This option was assumed by Orthofix in the merger and replaced with an option to purchase 7,417 shares of Orthofix at a price of $43.82 per share. F11: The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.01 · Expires 2028-01-01 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2023-01-05 · Disposition to issuer · Disposed 55,746 · Balance 0 F14: This option was assumed by Orthofix in the merger and replaced with an option to purchase 23,207 shares of Orthofix at a price of $28.85 per share. F13: The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.93 · Expires 2028-04-23 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2023-01-05 · Disposition to issuer · Disposed 6,089 · Balance 0 F16: This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,534 shares of Orthofix at a price of $23.86 per share. F15: The option fully vested and became exercisable on June 21, 2020. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.86 · Expires 2029-01-28 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2023-01-05 · Disposition to issuer · Disposed 69,128 · Balance 0 F18: This option was assumed by Orthofix in the merger and replaced with an option to purchase 28,777 shares of Orthofix at a price of $40.50 per share. F17: The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.67 · Expires 2030-02-28 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2023-01-05 · Disposition to issuer · Disposed 43,163 · Balance 0 F20: This option was assumed by Orthofix in the merger and replaced with an option to purchase 17,968 shares of Orthofix at a price of $30.44 per share. F19: The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.00 · Expires 2030-02-28 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2023-01-05 · Disposition to issuer · Disposed 21,704 · Balance 0 F21: This option was assumed by Orthofix in the merger and replaced with an option to purchase 9,035 shares of Orthofix at a price of $36.04 per share. F19: The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 42,696 Orthofix Medical Inc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.
F2: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock.
F3: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024.
F4: These restricted stock units were assumed by Orthofix in the merger and replaced by 5,761 Orthofix restricted stock units.
F5: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025.
F6: These restricted stock units were assumed by Orthofix in the merger and replaced by 21,562 Orthofix restricted stock units.
F7: The option vests as to 25% of the underlying shares on May 1, 2016 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F8: This option was assumed by Orthofix in the merger and replaced with an option to purchase 25,810 shares of Orthofix at a price of $37.67 per share.
F9: The option vests in sixteen substantially equal quarterly installments beginning on March 31, 2016.
F10: This option was assumed by Orthofix in the merger and replaced with an option to purchase 26,892 shares of Orthofix at a price of $34.09 per share.
F11: The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F12: This option was assumed by Orthofix in the merger and replaced with an option to purchase 7,417 shares of Orthofix at a price of $43.82 per share.
F13: The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F14: This option was assumed by Orthofix in the merger and replaced with an option to purchase 23,207 shares of Orthofix at a price of $28.85 per share.
F15: The option fully vested and became exercisable on June 21, 2020.
F16: This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,534 shares of Orthofix at a price of $23.86 per share.
F17: The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F18: This option was assumed by Orthofix in the merger and replaced with an option to purchase 28,777 shares of Orthofix at a price of $40.50 per share.
F19: The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F20: This option was assumed by Orthofix in the merger and replaced with an option to purchase 17,968 shares of Orthofix at a price of $30.44 per share.
F21: This option was assumed by Orthofix in the merger and replaced with an option to purchase 9,035 shares of Orthofix at a price of $36.04 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 01, 2019 Filed Jan 3, 2019 16:55 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantEmployee Stock Option (Right to Buy) · Derivative | 17,818 | $0.00 Strike: $18.24 | $0.00 |
DisclosureSEC source: 0001637761-19-000008 · wf-form4_154655251033451.xml · derivative · entry 7 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,818 Underlying: Common Stock · 17,818 shares Expires 2027-01-01 F6 · derivative.exercise_date: The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 16:55 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantRestricted Stock Units · Derivative | 16,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-19-000008 · wf-form4_154655251033451.xml · derivative · entry 6 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,037 Underlying: Common Stock · 16,037 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F5 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of January 1, 2020, 2021 and 2022. F5 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of January 1, 2020, 2021 and 2022. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 16:55 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionRestricted Stock Units · Derivative | 12,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-19-000008 · wf-form4_154655251033451.xml · derivative · entry 5 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,101 Underlying: Common Stock · 12,550 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · derivative.exercise_date: The reporting person was granted 37,651 restricted stock units on March 5, 2018, which vest in three equal installments on each of January, 1, 2019, 2020 and 2021. F4 · derivative.expiration_date: The reporting person was granted 37,651 restricted stock units on March 5, 2018, which vest in three equal installments on each of January, 1, 2019, 2020 and 2021. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 16:55 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionRestricted Stock Units · Derivative | 15,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-19-000008 · wf-form4_154655251033451.xml · derivative · entry 4 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,574 Underlying: Common Stock · 15,573 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The reporting person was granted 46,720 restricted stock units on February 2, 2017, which vest in three equal installments on each of January, 1, 2018, 2019 and 2020. F3 · derivative.expiration_date: The reporting person was granted 46,720 restricted stock units on February 2, 2017, which vest in three equal installments on each of January, 1, 2018, 2019 and 2020. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 16:55 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 10,144 | $18.24 | $185,026.56 |
DisclosureSEC source: 0001637761-19-000008 · wf-form4_154655251033451.xml · nonDerivative · entry 3 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,694 F2 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred on January 1, 2019. No shares were sold in connection with this transaction. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 16:55 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 12,550 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-19-000008 · wf-form4_154655251033451.xml · nonDerivative · entry 2 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 16:55 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 15,573 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-19-000008 · wf-form4_154655251033451.xml · nonDerivative · entry 1 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| March 23, 2018 Filed Apr 2, 2018 20:31 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 366 | $9.75 | $3,568.50 |
DisclosureSEC source: 0001637761-18-000063 · wf-form4_152271545049515.xml · nonDerivative · entry 1 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,715 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on March 23, 2018. No shares were sold in connection with this transaction. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 14:38 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantRestricted Stock Units · Derivative | 37,651 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-18-000055 · wf-form4_152045147063121.xml · derivative · entry 1 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,651 Underlying: Common Stock · 37,651 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of January 1, 2019, 2020 and 2021. F2 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of January 1, 2019, 2020 and 2021. Read SEC document |
| January 01, 2018 Filed Jan 3, 2018 19:00 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionRestricted Stock Units · Derivative | 15,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-18-000007 · wf-form4_151502399928650.xml · derivative · entry 3 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,147 Underlying: Common Stock · 15,573 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The reporting person was granted 46,720 restricted stock units on February 2, 2017, which vest in three equal installments on each of January 1, 2018, 2019 and 2020. F3 · derivative.expiration_date: The reporting person was granted 46,720 restricted stock units on February 2, 2017, which vest in three equal installments on each of January 1, 2018, 2019 and 2020. Read SEC document |
| January 01, 2018 Filed Jan 3, 2018 19:00 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 6,613 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-18-000007 · wf-form4_151502399928650.xml · nonDerivative · entry 2 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,081 F2 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on January 1, 2018. No shares were sold in connection with this transaction. Read SEC document |
| January 01, 2018 Filed Jan 3, 2018 19:00 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 15,573 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-18-000007 · wf-form4_151502399928650.xml · nonDerivative · entry 1 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,694 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| March 24, 2017 Filed Mar 27, 2017 15:18 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 1,435 | $7.32 | $10,504.20 |
DisclosureSEC source: 0001637761-17-000069 · wf-form4_149064230586975.xml · nonDerivative · entry 2 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,121 F2 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on March 24, 2017. No shares were sold in connection with this transaction. Read SEC document |
| March 23, 2017 Filed Mar 27, 2017 15:18 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 365 | $7.34 | $2,679.10 |
DisclosureSEC source: 0001637761-17-000069 · wf-form4_149064230586975.xml · nonDerivative · entry 1 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,556 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on March 23, 2017. No shares were sold in connection with this transaction. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 12:06 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionRestricted Stock Units · Derivative | 15,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-17-000055 · wf-form4_148950759462561.xml · derivative · entry 2 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,592 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. F2 · derivative.exercise_date: The reporting person was granted 15,592 restricted stock units on February 2, 2017, which vested in full on March 10, 2017. F2 · derivative.expiration_date: The reporting person was granted 15,592 restricted stock units on February 2, 2017, which vested in full on March 10, 2017. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 12:06 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 15,592 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-17-000055 · wf-form4_148950759462561.xml · nonDerivative · entry 1 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,921 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 16:14 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantRestricted Stock Units · Derivative | 46,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-17-000022 · wf-form4_148641564866382.xml · derivative · entry 2 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,720 Underlying: Common Stock · 46,720 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of January 1, 2018, 2019 and 2020. F3 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of January 1, 2018, 2019 and 2020. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 16:14 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantRestricted Stock Units · Derivative | 15,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-17-000022 · wf-form4_148641564866382.xml · derivative · entry 1 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,592 Underlying: Common Stock · 15,592 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on March 10, 2017. F2 · derivative.expiration_date: The restricted stock units vest in full on March 10, 2017. Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 12:54 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | PurchaseCommon Stock | 3,900 | $7.02 | $27,378.00 |
DisclosureSEC source: 0001637761-16-000143 · wf-form4_147983727097716.xml · nonDerivative · entry 5 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,329 F6 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.99 to $7.05, inclusive. The reporting person undertakes to provide to SeaSpine, any security holder of SeaSpine, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 01, 2016 Filed Nov 22, 2016 12:54 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 2,159 | $11.06 | $23,878.54 |
DisclosureSEC source: 0001637761-16-000143 · wf-form4_147983727097716.xml · nonDerivative · entry 4 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,429 F5 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on July 1, 2016. No shares were sold in connection with this transaction. Read SEC document |
| March 25, 2016 Filed Nov 22, 2016 12:54 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 1,030 | $14.08 | $14,502.40 |
DisclosureSEC source: 0001637761-16-000143 · wf-form4_147983727097716.xml · nonDerivative · entry 3 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,588 F3 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on March 25, 2016. No shares were sold in connection with this transaction. F4 · balance_after: As a result of the omission to reflect the withholding of shares that occurred on each of March 23, 24 and 25 2016, the Form 4 filed by the reporting person on May 23, 2016 overstated by 2,810 the amount of securities beneficially owned following the transaction reported in such Form 4. Read SEC document |
| March 24, 2016 Filed Nov 22, 2016 12:54 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 1,407 | $14.08 | $19,810.56 |
DisclosureSEC source: 0001637761-16-000143 · wf-form4_147983727097716.xml · nonDerivative · entry 2 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,618 F2 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on March 24, 2016. No shares were sold in connection with this transaction. Read SEC document |
| March 23, 2016 Filed Nov 22, 2016 12:54 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 373 | $14.23 | $5,307.79 |
DisclosureSEC source: 0001637761-16-000143 · wf-form4_147983727097716.xml · nonDerivative · entry 1 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,025 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on March 23, 2016. No shares were sold in connection with this transaction. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.